- Home
- IRS vs SYRE Comparison
IRS vs SYRE Comparison
Compare IRS & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRS
- SYRE
- Stock Information
- Founded
- IRS 1943
- SYRE 2013
- Country
- IRS Argentina
- SYRE United States
- Employees
- IRS N/A
- SYRE N/A
- Industry
- IRS Homebuilding
- SYRE Biotechnology: Pharmaceutical Preparations
- Sector
- IRS Real Estate
- SYRE Health Care
- Exchange
- IRS Nasdaq
- SYRE Nasdaq
- Market Cap
- IRS 1.1B
- SYRE 1.1B
- IPO Year
- IRS 1994
- SYRE 2016
- Fundamental
- Price
- IRS $14.32
- SYRE $17.00
- Analyst Decision
- IRS
- SYRE Buy
- Analyst Count
- IRS 0
- SYRE 5
- Target Price
- IRS N/A
- SYRE $55.00
- AVG Volume (30 Days)
- IRS 207.7K
- SYRE 438.9K
- Earning Date
- IRS 11-05-2025
- SYRE 08-05-2025
- Dividend Yield
- IRS 7.02%
- SYRE N/A
- EPS Growth
- IRS N/A
- SYRE N/A
- EPS
- IRS 0.20
- SYRE N/A
- Revenue
- IRS $393,157,502.00
- SYRE N/A
- Revenue This Year
- IRS N/A
- SYRE N/A
- Revenue Next Year
- IRS N/A
- SYRE N/A
- P/E Ratio
- IRS $6.51
- SYRE N/A
- Revenue Growth
- IRS 29.22
- SYRE N/A
- 52 Week Low
- IRS $10.61
- SYRE $10.91
- 52 Week High
- IRS $17.67
- SYRE $40.26
- Technical
- Relative Strength Index (RSI)
- IRS 43.17
- SYRE 53.61
- Support Level
- IRS $13.71
- SYRE $16.23
- Resistance Level
- IRS $15.06
- SYRE $17.44
- Average True Range (ATR)
- IRS 0.64
- SYRE 0.83
- MACD
- IRS -0.13
- SYRE 0.01
- Stochastic Oscillator
- IRS 28.63
- SYRE 61.35
About IRS IRSA Inversiones Y Representaciones S.A. Global Depositary Shares (Each representing ten shares of)
IRSA Inversiones y Representaciones SA is engaged in a diversified business. The company's operating segment includes Shopping Malls; Offices; Sales and Developments; Hotels and others. It generates maximum revenue from the Shopping Malls segment. The Shopping Malls segment comprised of lease and service revenues related to rental of commercial space and other spaces in the shopping malls of the company.
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.